Pharmaceuticals UAE

UAE Sickle Cell Disease Therapeutics Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

UAE Sickle Cell Disease Therapeutics Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Age, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

UAE · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $16.7 Mn Placeholder estimate
Estimate 2025 $19.9 Mn 0.5% of the global market
Projected 2034 $97.5 Mn 389.5% Adds $77.6 Mn over 9 forecast years
CAGR 2025–2034 19.3% Faster than 84% of 180 Pharmaceuticals markets here
Key players 5
  • UAE is 0.51% of the global market.
  • In Middle East, the largest is Saudi Arabia at $73.7 Mn.
  • Fastest growing: UAE (this report) at 19.3% a year.
  • UAE ranks 2nd of 2 by size in Middle East.

Market size projection

UAE

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$77.6 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Sickle Cell Disease Therapeutics Market market size by year, UAE
YearMarket sizeChange that yearSince 2025
2024 (estimate) $16.7 Mn — —
2025 (base) $19.9 Mn +$3.2 Mn —
2026 (forecast) $23.8 Mn +$3.8 Mn +19.3%
2027 (forecast) $28.4 Mn +$4.6 Mn +42.3%
2028 (forecast) $33.8 Mn +$5.5 Mn +69.8%
2029 (forecast) $40.4 Mn +$6.5 Mn +102.6%
2030 (forecast) $48.2 Mn +$7.8 Mn +141.7%
2031 (forecast) $57.4 Mn +$9.3 Mn +188.3%
2032 (forecast) $68.5 Mn +$11.1 Mn +243.9%
2033 (forecast) $81.8 Mn +$13.2 Mn +310.3%
2034 (forecast) $97.5 Mn +$15.8 Mn +389.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $3.90 Bn
  2. North America $2.17 Bn
  3. US $1.54 Bn
  4. Europe $794.9 Mn
  5. APAC $820.8 Mn
  6. China $333.9 Mn
  7. Canada $279.2 Mn
  8. Japan $264.4 Mn
  9. Latin America $190.0 Mn
  10. Middle East $148.5 Mn
  11. Germany $126.8 Mn
  12. France $112.3 Mn
  13. UK $105.3 Mn
  14. Italy $90.6 Mn
  15. Brazil $90.1 Mn
  16. Spain $80.4 Mn
  17. Ecuador $78.8 Mn
  18. India $78.5 Mn
  19. Saudi Arabia $73.7 Mn
  20. Mexico $57.4 Mn
  21. Australia $52.3 Mn
  22. Africa $51.1 Mn
  23. New Zealand $37.9 Mn
  24. Russia $35.4 Mn
  25. South Africa $23.7 Mn
  26. UAE (this report) $19.9 Mn
  27. Egypt $12.1 Mn
  28. Philippines $9.7 Mn
  29. Malaysia $6.0 Mn
  30. Hong Kong $5.5 Mn
  31. Singapore $4.9 Mn
  32. Thailand $4.2 Mn
  33. Kenya $3.1 Mn

Report snapshot

UAE Sickle Cell Disease Therapeutics Market Analysis at a glance
Market size, 2025$19.9 Mn placeholder estimate
Forecast, 2034$97.5 Mn placeholder estimate
Growth (CAGR), 2025–203419.3% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
Also calledSickle Cell Disease Treatment
SegmentsTreatment, age and end user (see all)
Key playersVertex Pharmaceuticals, bluebird bio, Pfizer Inc., Novartis AG, Novo Nordisk A/S (see all)
Regulator in the UAEEDESource: Emirates Drug Establishment. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The UAE Sickle Cell Disease Therapeutics Market Analysis Executive Summary

Sickle cell disease therapeutics include gene therapies, gene editing and medicines that reduce pain crises and organ damage.

Key segments of the sickle Cell Disease Therapeutics market include treatment (Gene Therapy, Gene Editing and Hydroxyurea) and age (Pediatric and Adult).

Bar chart: UAE Sickle Cell Disease Therapeutics market size, 2024–2034, placeholder estimates. $16.7 Mn in 2024, $19.9 Mn in 2025 and $97.5 Mn in 2034, 19.3% CAGR.
UAE Sickle Cell Disease Therapeutics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

UAE Sickle Cell Disease Therapeutics Market Dynamics

Market Growth Drivers

Approvals of the first curative gene and cell therapies, strong investment in biotech, better manufacturing and growing evidence in rare and blood diseases are driving the sickle Cell Disease Therapeutics market.

Opportunity

Allogeneic (off-the-shelf) products, in-vivo delivery and use in common diseases open large growth for the sickle Cell Disease Therapeutics market.

Market Restraints

Very high prices, complex manufacturing, limited treatment centres and uncertain long-term safety hold back the sickle Cell Disease Therapeutics market. Payers are still working out how to pay for one-time cures.

Competitive Landscape for Sickle Cell Disease Therapeutics Market in UAE

The sickle Cell Disease Therapeutics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Sickle Cell Disease Therapeutics Market in UAE

Sickle Cell Disease Therapeutics in the UAE: rules and payment

The Emirates Drug Establishment (EDE), set up in 2023, is taking over the regulation of medicines from the Ministry of Health and Prevention.⁠[1] Since January 2025, basic health insurance has been mandatory for all private-sector employees and domestic workers in every emirate.⁠[2]

[1] Emirates Drug Establishment. Checked 14 Nov 2026.

[2] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for sickle Cell Disease Therapeutics. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in UAE.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Sickle Cell Disease Therapeutics right now, from free public sources.

Latest research 3,466 papers since 2021 (worldwide)

  1. Health-related quality of life among adults with sickle cell disease in India: a multicentric longitudinal study of associated factors and calendar-season differences. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2026
  2. A non-IMiD multi-target degrader reactivates fetal hemoglobin. Experimental hematology & oncology, 2026
  3. Red Blood Cell Exchange in a Resource-Variable Setting: A Scoping Review of Two Decades of Indian Experience. Journal of clinical apheresis, 2026
  4. Awareness and Acceptance of Gene Therapy for Sickle Cell Disease Among Individuals From the Eastern Province of Saudi Arabia: A Cross-Sectional Study. Health science reports, 2026
  5. Gene therapy for hemoglobinopathies. Seminars in hematology, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Sickle Cell Disease Therapeutics in context

The UAE compared

  • Health spending per person: 2,402 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 9 countries we cover in Middle East.[1]
  • Doctors: 2.99 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 3rd highest of the 9 countries we cover in Middle East.[2]
  • People aged 65 and over: 1.8% of people (2025). World: 10.4% of people (2025). 8th highest of the 9 countries we cover in Middle East.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Sickle Cell Disease Therapeutics market in the UAE?
Placeholder estimate: about $19.9 Mn in 2025, rising to about $97.5 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Sickle Cell Disease Therapeutics market in the UAE growing?
Placeholder estimate: about 19.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Sickle Cell Disease Therapeutics market report cover?
The report splits the market by treatment (Gene Therapy, Gene Editing, Hydroxyurea, Disease-Modifying Drugs), age (Pediatric, Adult) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Sickle Cell Disease Therapeutics market?
Key players include Vertex Pharmaceuticals, bluebird bio, Pfizer Inc., Novartis AG and Novo Nordisk A/S.
What is driving the Sickle Cell Disease Therapeutics market?
Approvals of the first curative gene and cell therapies, strong investment in biotech, better manufacturing and growing evidence in rare and blood diseases are driving the sickle Cell Disease Therapeutics market.
Who regulates Sickle Cell Disease Therapeutics in the UAE?
The Emirates Drug Establishment (EDE), set up in 2023, is taking over the regulation of medicines from the Ministry of Health and Prevention. Source: Emirates Drug Establishment. Checked 14 Nov 2026.
How is healthcare paid for in the UAE?
Since January 2025, basic health insurance has been mandatory for all private-sector employees and domestic workers in every emirate. Source: Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.
How much research is published on Sickle Cell Disease Therapeutics?
PubMed lists 3,466 papers on Sickle Cell Disease Therapeutics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Sickle Cell Disease Therapeutics in UAE? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Women's Health Supplements: A Growing FocusAnaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth… Iron Supplements and the Fight Against AnaemiaIron supplements are the first line against anaemia. Why taking them is the hard part, and how the market is… Vitamin B12: The Deficiency Many People MissVitamin B12 comes almost only from animal foods. Vegetarians, older adults and people on some medicines are…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in UAE

See all
Same topic, other categories

Related on rare diseases and anemia

See the topic